|
Positive results in Southampton-led patient trial for new asthma treatment
EurekAlert (press release) This pioneering trial investigated the potential for SNG001 to protect asthmatics from respiratory virus infections, principally the common cold, that can spread to the lung, which are a major cause of worsening asthma symptoms. Synairgen no wheeze as asthma drug trial boosts shares |
View full post on asthma – Google News